Study population
Healthy Chinese males and females aged 18–55 years with a body mass index (BMI) of 18–28 kg/mThis study was carried out in accordance with the recommendations of Good Clinical Practice and the Declaration of Helsinki. The study protocol was approved by the Ethics Committee of the First Hospital of Jilin University, Changchun, Jilin, China. All participants provided written informed consent in accordance with the Declaration of Helsinki, and the clinical trial registration number was ChiCTR1800019570 (